BPC-157/TB-500 10 mg Blend
- Active Substance: Thymosin beta 4 / Pentadecapeptide (5 mg BPC-157 + 5 mg TB-500)
- Concentration: 10 mg per vial (5 mg each peptide)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (BPC-157): C62H98N16O22
- Molecular Weight (BPC-157): 1419.54 g/mol
- Sequence (BPC-157): Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Pro-Pro-Ala-Glu-Gly-Lys
- Molecular Formula (TB-500): C38H68N10O14
- Molecular Weight (TB-500): 889.01 g/mol
- Sequence (TB-500): Ac-LKKTETQ
- Synonyms: BPC-157 (Body Protection Compound-157), TB-500 (Thymosin Beta-4 fragment)
BPC-157/TB-500 10 mg – Orchestrate a Symphony of Recovery
Product Summary
Picture a research frontier where injuries heal with precision and speed, orchestrated by a powerful synergy of science. BPC-157/TB-500 10 mg vial from Peptide Sciences USA combines two potent peptides—BPC-157 and TB-500—to accelerate tissue repair, reduce inflammation, and enhance recovery. This elite blend is a cornerstone for researchers exploring regenerative medicine, offering a transformative approach to healing studies.
How BPC-157/TB-500 Blend Works
The BPC-157/TB-500 blend combines Body Protection Compound-157 (BPC-157), a pentadecapeptide from human gastric juice, with TB-500, a synthetic fragment of Thymosin Beta-4. BPC-157 (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Pro-Pro-Ala-Glu-Gly-Lys) promotes angiogenesis via vascular endothelial growth factor (VEGF) upregulation, enhances collagen deposition, and reduces proinflammatory cytokines like TNF-α. TB-500 (sequence: Ac-LKKTETQ) regulates actin dynamics, facilitating cell migration and tissue regeneration by amplifying microRNA-146a, which represses inflammation-related cytokines (IL-1, TRAF6).
Their synergy is profound: BPC-157 improves blood flow and tissue repair, while TB-500 drives fibroblast and immune cell migration to injury sites, enhancing structural integrity. Preclinical studies show BPC-157 accelerates tendon healing by 30–50% in rats, while TB-500 supports wound healing in pressure ulcer models, with combined use reducing recovery times by up to 40% in animal models. This blend's complementary pathways make it a leading candidate for researching soft tissue injuries, joint repair, and inflammation control.
Why Choose BPC-157/TB-500 10 mg?
The BPC-157/TB-500 blend is a trailblazer in regenerative research, harmonizing two peptides for unparalleled results. Here's why it excels:
- Synergistic Healing: Combines BPC-157's angiogenesis and TB-500's cell migration to accelerate tissue repair by up to 40% in preclinical models.
- Reduced Inflammation: Suppresses proinflammatory cytokines, easing swelling and pain in models of arthritis and colitis.
- Versatile Recovery: Supports healing of muscles, tendons, ligaments, nerves, and gut tissues, broadening research applications.
- Enhanced Tissue Integrity: Promotes collagen and actin dynamics, reducing scar tissue and improving repair quality.
- Elite Quality: Peptide Sciences USA ensures 99% purity, delivering a reliable platform for cutting-edge research.
BPC-157/TB-500 10 mg empowers researchers to orchestrate breakthroughs in healing, backed by the prestige of advanced peptide science.
Product Specifications
Peptide Sciences USA's BPC-157/TB-500 10 mg vial is engineered for excellence in regenerative research, offering unmatched quality. Here's the details:
- Composition: Contains 10 mg total (5 mg BPC-157, C62H98N16O22, 1419.54 g/mol; 5 mg TB-500, C38H68N10O14, 889.01 g/mol).
- Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous or intramuscular injection.
- Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
- Usage Guidelines: Reconstitute with bacteriostatic water and administer subcutaneously or intramuscularly, typically at 500–1000 mcg daily (250–500 mcg each peptide) in research protocols. Use under professional supervision.
- Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
- Safety: Preclinical studies report minimal side effects, such as mild injection site reactions; limited human data requires research oversight.
This peptide blend is for research purposes only, providing a cutting-edge platform for studying synergistic healing.
Legal Disclaimer
BPC-157/TB-500 10 mg is supplied for research purposes only and is not FDA-approved for human use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.
Frequently Asked Questions
What is BPC-157/TB-500 10 mg blend?
The BPC-157/TB-500 10 mg blend combines 5 mg of BPC-157, a pentadecapeptide from human gastric juice, with 5 mg of TB-500, a Thymosin Beta-4 fragment. It's designed for research into synergistic tissue repair and inflammation reduction.
What does BPC-157/TB-500 blend do for your body?
In research models, the blend promotes angiogenesis, collagen deposition, and cell migration, accelerating healing of muscles, tendons, ligaments, and nerves by up to 40%. It also reduces inflammation and supports gut health.
How much BPC-157/TB-500 blend 10 mg should I take daily?
Research protocols typically involve 500–1000 mcg daily (250–500 mcg each peptide) via subcutaneous or intramuscular injection, adjusted based on study design. Professional guidance is essential.
What are the potential side effects of the BPC-157/TB-500 blend?
Preclinical studies report minimal side effects, such as mild injection site redness or fatigue. Limited human data necessitates professional oversight for research safety.
How is the BPC-157/TB-500 blend administered?
The blend is supplied as a 10 mg lyophilized powder. Reconstitute with bacteriostatic water and inject subcutaneously or intramuscularly near the injury site, typically at 500–1000 mcg daily in research protocols.
Related Products
- Active Substance: Thymosin Beta 4 (TB-500) + BPC-157 Pentadecapeptide
- Concentration: 5 mg TB-500 + 5 mg BPC-157 per vial
- Pack Size: 1 vial (lyophilized blend for reconstitution)
- Manufacturer: Dragon Pharma
- Brand Name: Peptide Blend
- Synonyms: BPC-TB Blend, Thymosin Beta-4 + BPC Research Formula, Regenerative Peptide Combo
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)